Abstract
More eyes treated with intravitreal aflibercept in PANORAMA achieved ≥2-step improvement in DRSS score and fewer developed vision-threatening complications and/or CI-DME versus sham, consistently across all baseline demographic and disease characteristic subgroups assessed.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
